Department of Anesthesiology (G.A., D.J.S., A.L.G., J.H.S.) and Taylor Family Institute for Innovative Psychiatric Research (G.A., J.H.S.), Washington University School of Medicine, St. Louis, Missouri
Department of Anesthesiology (G.A., D.J.S., A.L.G., J.H.S.) and Taylor Family Institute for Innovative Psychiatric Research (G.A., J.H.S.), Washington University School of Medicine, St. Louis, Missouri.
Mol Pharmacol. 2018 Feb;93(2):90-100. doi: 10.1124/mol.117.110569. Epub 2017 Nov 17.
The concerted transition model for multimeric proteins is a simple formulation for analyzing the behavior of transmitter-gated ion channels. We used the model to examine the relationship between the EC for activation of the GABA type A (GABA) receptor by the transmitter GABA and basal activity employing concatemeric ternary GABA receptors expressed in oocytes. Basal activity, reflecting the receptor function in the absence of the transmitter, can be changed either by mutation to increase constitutive activity or by the addition of a second agonist (acting at a different site) to increase background activity. The model predicts that either mechanism for producing a change in basal activity will result in identical effects on the EC We examined receptor activation by GABA while changing the level of basal activity with the allosterically acting anesthetics propofol, pentobarbital, or alfaxalone. We found that the relationship between EC and basal activity was well described by the concerted transition model. Changes in the basal activity by gain-of-function mutations also resulted in predictable changes in the EC Finally, we altered the number of GABA-binding sites by a mutation and again found that the relationship could be well described by the model. Overall, the results support the idea that interactions between the transmitter GABA and the allosteric agonists propofol, pentobarbital, or alfaxalone can be understood as reflecting additive and independent free energy changes, without assuming any specific interactions.
三聚体蛋白协同转变模型是分析递质门控离子通道行为的一种简单方法。我们使用该模型,通过在卵母细胞中表达串联的三聚体 GABA 受体,研究了 GABA 型 A 受体(GABAAR)被递质 GABA 激活的 EC 与基础活性之间的关系。基础活性反映了在没有递质的情况下受体的功能,可以通过突变增加组成性活性来改变,也可以通过添加第二种激动剂(作用于不同的位点)来增加背景活性。该模型预测,产生基础活性变化的任何机制都将对 EC 产生相同的影响。我们在改变基础活性水平的同时,通过变构作用麻醉剂异丙酚、戊巴比妥或阿法沙龙来检测 GABA 对受体的激活作用。我们发现,EC 与基础活性之间的关系很好地符合协同转变模型。通过获得功能突变改变基础活性也会导致 EC 的可预测变化。最后,我们通过突变改变 GABA 结合位点的数量,再次发现该模型可以很好地描述这种关系。总的来说,这些结果支持这样一种观点,即递质 GABA 与变构激动剂异丙酚、戊巴比妥或阿法沙龙之间的相互作用可以被理解为反映了加和的、独立的自由能变化,而无需假设任何特定的相互作用。